N. Vachharajani

870 total citations
12 papers, 738 citations indexed

About

N. Vachharajani is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, N. Vachharajani has authored 12 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in N. Vachharajani's work include Diabetes Treatment and Management (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Potassium and Related Disorders (2 papers). N. Vachharajani is often cited by papers focused on Diabetes Treatment and Management (3 papers), Pharmacogenetics and Drug Metabolism (2 papers) and Potassium and Related Disorders (2 papers). N. Vachharajani collaborates with scholars based in United States, Germany and Sweden. N. Vachharajani's co-authors include David M. Kornhauser, Bernard J. Komoroski, Marc Pfister, Feng Yan, David W. Boulton, Margarida Geraldes, W. A. Ritschel, Azher Hussain, Robert D. Johnson and Chirag G. Patel and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Diabetes Obesity and Metabolism and Cephalalgia.

In The Last Decade

N. Vachharajani

11 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Vachharajani United States 6 606 374 361 108 57 12 738
Paul Strumph United States 14 1.2k 1.9× 811 2.2× 294 0.8× 82 0.8× 37 0.6× 25 1.3k
Yoshishige Samukawa Japan 13 759 1.3× 336 0.9× 399 1.1× 138 1.3× 207 3.6× 25 918
Yuka Hayashizaki Japan 8 588 1.0× 317 0.8× 299 0.8× 70 0.6× 57 1.0× 9 750
Farshad Kajbaf France 14 475 0.8× 165 0.4× 398 1.1× 44 0.4× 95 1.7× 24 801
Russell Esterline United States 15 282 0.5× 153 0.4× 214 0.6× 59 0.5× 38 0.7× 26 589
Chiaki Kuriyama Japan 9 343 0.6× 267 0.7× 178 0.5× 32 0.3× 25 0.4× 13 464
Yasuhiro Tahara Japan 11 520 0.9× 234 0.6× 142 0.4× 26 0.2× 29 0.5× 33 732
Markus Daschner Germany 9 194 0.3× 166 0.4× 173 0.5× 42 0.4× 121 2.1× 12 467
S Aronoff United States 6 392 0.6× 118 0.3× 345 1.0× 79 0.7× 41 0.7× 6 643
Yukiko Takemura Japan 5 260 0.4× 176 0.5× 179 0.5× 43 0.4× 20 0.4× 7 431

Countries citing papers authored by N. Vachharajani

Since Specialization
Citations

This map shows the geographic impact of N. Vachharajani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Vachharajani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Vachharajani more than expected).

Fields of papers citing papers by N. Vachharajani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Vachharajani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Vachharajani. The network helps show where N. Vachharajani may publish in the future.

Co-authorship network of co-authors of N. Vachharajani

This figure shows the co-authorship network connecting the top 25 collaborators of N. Vachharajani. A scholar is included among the top collaborators of N. Vachharajani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Vachharajani. N. Vachharajani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Patel, Chirag G., David M. Kornhauser, N. Vachharajani, et al.. (2011). Saxagliptin, a potent, selective inhibitor of DPP‐4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects. Diabetes Obesity and Metabolism. 13(7). 604–614. 18 indexed citations
2.
Komoroski, Bernard J., N. Vachharajani, David W. Boulton, et al.. (2009). Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects. Clinical Pharmacology & Therapeutics. 85(5). 520–526. 288 indexed citations
3.
Komoroski, Bernard J., et al.. (2009). Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus. Clinical Pharmacology & Therapeutics. 85(5). 513–519. 338 indexed citations
4.
Boulton, David W., Gary H. Duncan, & N. Vachharajani. (2002). Validation and application of a sensitive assay for butorphanol in human plasma by high-performance liquid chromatography with tandem mass spectrometry detection. Journal of Chromatography B. 775(1). 57–62. 3 indexed citations
5.
6.
Kostis, John B., et al.. (2001). The Pharmacokinetics and Pharmacodynamics of Irbesartan in Heart Failure. The Journal of Clinical Pharmacology. 41(9). 935–942. 12 indexed citations
7.
Vachharajani, N., et al.. (1999). Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects. Clinical Pharmacology & Therapeutics. 65(2). 180–180. 1 indexed citations
8.
Stouffer, Bruce, et al.. (1999). Validation of an Elisa for the Quantitation of Lanoteplase, A Novel Plasminogen Activator. Journal of Immunoassay. 20(4). 237–252. 4 indexed citations
9.
Vachharajani, N., et al.. (1998). Effects of Food on the Pharmacokinetics of Irbesartan/Hydrochlorothiazide Combination Tablet. Clinical Drug Investigation. 16(5). 399–404. 4 indexed citations
10.
Ritschel, W. A., N. Vachharajani, Robert D. Johnson, & Azher Hussain. (1992). The allometric approach for interspecies scaling of pharmacokinetic parameters. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 103(2). 249–253. 50 indexed citations
11.
Ritschel, W. A., et al.. (1992). Prediction of the volume of distribution of 7‐hydroxycoumarin in man from in vitro and ex vivo data obtained in rat. Biopharmaceutics & Drug Disposition. 13(6). 389–402. 3 indexed citations
12.
Ritschel, W. A. & N. Vachharajani. (1992). Review of electrolyte pharmacokinetics.. PubMed. 14(4). 241–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Strumph Breakdown of academic impact, for papers by Yoshishige Samukawa Breakdown of academic impact, for papers by Yuka Hayashizaki Breakdown of academic impact, for papers by Farshad Kajbaf Breakdown of academic impact, for papers by Russell Esterline Breakdown of academic impact, for papers by Chiaki Kuriyama Breakdown of academic impact, for papers by Yasuhiro Tahara Breakdown of academic impact, for papers by Markus Daschner Breakdown of academic impact, for papers by S Aronoff Breakdown of academic impact, for papers by Yukiko Takemura
Rankless by CCL
2026